Annual Short Term Debt
$1.63 M
+$1.18 M+260.26%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual short term debt is $1.63 million, with the most recent change of +$1.18 million (+260.26%) on December 1, 2023.
- During the last 3 years, NBY annual short term debt has risen by +$1.22 million (+292.31%).
- NBY annual short term debt is now -53.91% below its all-time high of $3.54 million, reached on December 31, 2019.
Performance
NBY Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$441.00 K
-$637.00 K-59.09%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly short term debt is $441.00 thousand, with the most recent change of -$637.00 thousand (-59.09%) on September 1, 2024.
- Over the past year, NBY quarterly short term debt has dropped by -$1.31 million (-74.87%).
- NBY quarterly short term debt is now -89.25% below its all-time high of $4.10 million, reached on September 30, 2019.
Performance
NBY Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NBY Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +260.3% | -74.9% |
| 3 y3 years | +292.3% | -73.5% |
| 5 y5 years | +100.0% | -73.5% |
NBY Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +435.1% | -74.9% | +44.6% |
| 5 y | 5-year | -53.9% | +435.1% | -87.5% | +126.2% |
| alltime | all time | -53.9% | -100.0% | -89.3% | -100.0% |
NovaBay Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $441.00 K(-59.1%) |
| Jun 2024 | - | $1.08 M(-22.0%) |
| Mar 2024 | - | $1.38 M(-15.3%) |
| Dec 2023 | $1.63 M(+260.3%) | $1.63 M(-7.0%) |
| Sep 2023 | - | $1.75 M(+5.7%) |
| Jun 2023 | - | $1.66 M(+256.4%) |
| Mar 2023 | - | $466.00 K(+2.9%) |
| Dec 2022 | $453.00 K(+48.5%) | $453.00 K(+1.8%) |
| Sep 2022 | - | $445.00 K(-5.3%) |
| Jun 2022 | - | $470.00 K(+1.1%) |
| Mar 2022 | - | $465.00 K(+52.5%) |
| Dec 2021 | $305.00 K(-26.7%) | $305.00 K(+56.4%) |
| Sep 2021 | - | $195.00 K(-34.6%) |
| Jun 2021 | - | $298.00 K(-24.7%) |
| Mar 2021 | - | $396.00 K(-4.8%) |
| Dec 2020 | $416.00 K(-88.3%) | $416.00 K(-17.5%) |
| Sep 2020 | - | $504.00 K(-55.8%) |
| Jun 2020 | - | $1.14 M(-61.7%) |
| Mar 2020 | - | $2.98 M(-15.9%) |
| Dec 2019 | $3.54 M | $3.54 M(-13.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $4.10 M(+285.3%) |
| Jun 2019 | - | $1.06 M(-49.1%) |
| Mar 2019 | - | $2.09 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Mar 2011 | - | $42.00 K(-60.4%) |
| Dec 2010 | $106.00 K(-71.4%) | $106.00 K(-36.9%) |
| Sep 2010 | - | $168.00 K(-38.0%) |
| Jun 2010 | - | $271.00 K(-17.9%) |
| Mar 2010 | - | $330.00 K(-11.1%) |
| Dec 2009 | $371.00 K(-9.1%) | $371.00 K(-10.6%) |
| Sep 2009 | - | $415.00 K(-0.2%) |
| Jun 2009 | - | $416.00 K(+0.2%) |
| Mar 2009 | - | $415.00 K(+1.7%) |
| Dec 2008 | $408.00 K(+59.4%) | $408.00 K(+2.8%) |
| Sep 2008 | - | $397.00 K(+2.3%) |
| Jun 2008 | - | $388.00 K(+23.6%) |
| Mar 2008 | - | $314.00 K(+22.7%) |
| Dec 2007 | $256.00 K | $256.00 K(+50.6%) |
| Sep 2007 | - | $170.00 K(+3.0%) |
| Jun 2007 | - | $165.00 K(+385.3%) |
| Mar 2007 | - | $34.00 K |
FAQ
- What is NovaBay Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual short term debt year-on-year change?
- What is NovaBay Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly short term debt year-on-year change?
What is NovaBay Pharmaceuticals annual short term debt?
The current annual short term debt of NBY is $1.63 M
What is the all time high annual short term debt for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual short term debt is $3.54 M
What is NovaBay Pharmaceuticals annual short term debt year-on-year change?
Over the past year, NBY annual short term debt has changed by +$1.18 M (+260.26%)
What is NovaBay Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of NBY is $441.00 K
What is the all time high quarterly short term debt for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly short term debt is $4.10 M
What is NovaBay Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, NBY quarterly short term debt has changed by -$1.31 M (-74.87%)